These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1001 related articles for article (PubMed ID: 23111773)
1. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773 [TBL] [Abstract][Full Text] [Related]
2. The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi. Sand M; Skrygan M; Georgas D; Sand D; Gambichler T; Altmeyer P; Bechara FG Cell Tissue Res; 2012 Oct; 350(1):119-26. PubMed ID: 22706980 [TBL] [Abstract][Full Text] [Related]
3. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma. Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055 [TBL] [Abstract][Full Text] [Related]
4. Expression of microRNAs in basal cell carcinoma. Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308 [TBL] [Abstract][Full Text] [Related]
5. Signatures of microRNAs and selected microRNA target genes in human melanoma. Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294 [TBL] [Abstract][Full Text] [Related]
6. Molecular Markers in Melanoma Progression: A Study on the Expression of miRNA Gene Subtypes in Tumoral vs. Benign Nevi. Prodan M; Costescu S; Elagez A; Laitin SMD; Bloanca V; Crainiceanu Z; Seclaman E; Toma AO; Fericean RM; Puenea G; Cozma GV Curr Oncol; 2024 May; 31(5):2881-2894. PubMed ID: 38785501 [TBL] [Abstract][Full Text] [Related]
7. Microrna profiling analysis of differences between the melanoma of young adults and older adults. Jukic DM; Rao UN; Kelly L; Skaf JS; Drogowski LM; Kirkwood JM; Panelli MC J Transl Med; 2010 Mar; 8():27. PubMed ID: 20302635 [TBL] [Abstract][Full Text] [Related]
8. The microRNA molecular signature of atypic and common acquired melanocytic nevi: differential expression of miR-125b and let-7c. Holst LM; Kaczkowski B; Glud M; Futoma-Kazmierczak E; Hansen LF; Gniadecki R Exp Dermatol; 2011 Mar; 20(3):278-80. PubMed ID: 21166724 [TBL] [Abstract][Full Text] [Related]
9. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis. Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864 [TBL] [Abstract][Full Text] [Related]
10. Global microRNA profiling of metastatic conjunctival melanoma. Mikkelsen LH; Andersen MK; Andreasen S; Larsen AC; Tan Q; Toft PB; Wadt K; Heegaard S Melanoma Res; 2019 Oct; 29(5):465-473. PubMed ID: 30932942 [TBL] [Abstract][Full Text] [Related]
11. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma. Yang M; Liu R; Sheng J; Liao J; Wang Y; Pan E; Guo W; Pu Y; Yin L Oncol Rep; 2013 Jan; 29(1):169-76. PubMed ID: 23124769 [TBL] [Abstract][Full Text] [Related]
12. [Differential expression profile of microRNA between hyperplastic scar and normal skin]. Ning P; Liu DW; Mao YG; Peng Y; Lin ZW; Liu DM Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(10):692-4. PubMed ID: 22781298 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression patterns of the microRNA-processing enzyme Dicer in cutaneous malignant melanomas, benign melanocytic nevi and dysplastic melanocytic nevi. Sand M; Gambichler T; Sand D; Altmeyer P; Stuecker M; Bechara FG Eur J Dermatol; 2011; 21(1):18-21. PubMed ID: 21262599 [TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of primary cutaneous melanoma. Winnepenninckx V; Van den Oord JJ Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling. Glud M; Klausen M; Gniadecki R; Rossing M; Hastrup N; Nielsen FC; Drzewiecki KT J Invest Dermatol; 2009 May; 129(5):1219-24. PubMed ID: 19005486 [TBL] [Abstract][Full Text] [Related]
16. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma. Su BB; Zhou SW; Gan CB; Zhang XN J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692 [TBL] [Abstract][Full Text] [Related]
18. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles. Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow. Gao J; Yang T; Han J; Yan K; Qiu X; Zhou Y; Fan Q; Ma B J Cell Biochem; 2011 Jul; 112(7):1844-56. PubMed ID: 21416501 [TBL] [Abstract][Full Text] [Related]